Traws Pharma, Inc. (ticker: TRAW) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of TRAW's SEC filings surfaces 4 active risk signals, including 2 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. TRAW reported $2.79M in revenue and $9.17M for the period ending 2025-12-31, with operating cash flow of -$18.18M. Cash and equivalents stood at $3.82M (down 82.1% year-over-year). Total assets of $10.62M are exceeded by total liabilities of $11.25M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
TRAW Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Traws Pharma, Inc. (TRAW) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.